Back to MW Marshall Wace, LLP
HBIO
Showing 2 of 16 quarters
Position history for MWMarshall Wace, LLP's holdings in Harvard Bioscience, Inc.
No. Marshall Wace exited its HBIO (Harvard Bioscience) position in Q3 2025. Its Q2 2025 13F listed 138,700 shares worth $61,028. Marshall Wace already held HBIO in its Q4 2018 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$61,028
Total Shares Change
-138,700
Quarter-by-Quarter History